Home / Guides / Tirzepatide pen vs. vial

Click or draw. Here’s the real difference.

Tirzepatide pen vs. vial: which is right for you?

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

A tirzepatide pen injects a preset dose and a vial needs a syringe; LillyDirect sells Zepbound’s KwikPen and vials from $299 a month at 2.5 mg (checked November 1, 2026). Compounded tirzepatide usually comes in a multiple-dose vial, and it isn’t FDA-approved.

  • Pens: a preset dose, sold as Zepbound
  • Vials: you draw the dose; compounded usually comes this way
  • Units: depend on your vial’s strength

Pen vs. vial at a glance

Pens
Zepbound single-dose pen, or the 4-dose KwikPen: the dose is set for you
Vials
Zepbound single-dose or 4-dose vials; compounded tirzepatide in multiple-dose vials
Self-pay price
Zepbound from $299 a month at LillyDirect; compounded $139 at NexLife on 12 months ($169 month to month)
Storage
In the fridge at 36°F to 46°F, never frozen
Units on a syringe
Depend on your vial’s strength in mg per mL

First time drawing a dose? Call or text (949) 818-8000 and we’ll talk you through it.

Check my eligibility

4.8 out of 5 on Trustpilot · LegitScript certified

About 3 minutes of health questions. No insurance needed. Compounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.

Compare

How do tirzepatide pens and vials compare on price and storage?

Tirzepatide pens and vials, side by side
Zepbound pensZepbound vialsCompounded vials
How you take itClick to inject a preset dose; the KwikPen holds 4 weekly dosesDraw your dose with a syringe; single-dose vials, or 4-dose vialsDraw your dose with a syringe from a multiple-dose vial
FDA-approvedYesYesNo
Self-pay priceKwikPen from $299 a month at LillyDirect$299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg to 15 mg with a refill within 45 days ($499 at 7.5 mg and $699 at 10 to 15 mg otherwise) at LillyDirect$139 to $399 a month, month to month, in our price index. At NexLife: $139 a month on the 12-month plan, every dose
Out of the fridgeSingle-dose pen: up to 21 days, up to 86°F. KwikPen in use: fridge or up to 86°FSingle-dose vial: up to 21 days, up to 86°F. 4-dose vial in use: fridge or up to 86°FOnly if the label on your vial says so
Once openedKwikPen: 4 weekly doses, within 30 days of first use4-dose vial: 4 weekly doses, within 30 days of first useWithin 28 days of the first needle, or the label’s date if sooner

Prices checked November 1, 2026. Compounded tirzepatide isn’t FDA-approved; Zepbound is. Paying less for compounded tirzepatide or semaglutide somewhere else? NexLife matches your regular monthly price.†

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • Pen: a preset dose. Vial: you draw it. Zepbound comes both ways, from $299 a month at LillyDirect (checked November 1, 2026).
  • The KwikPen holds 4 weekly doses. Zepbound also comes in single-dose pens and vials, and in 4-dose vials.
  • Compounded tirzepatide usually comes in a multiple-dose vial you draw with a syringe. It isn’t FDA-approved; Zepbound is.
  • Vials take math: units on a U-100 syringe = your dose in mg ÷ your vial’s mg per mL × 100.
  • Keep it in the fridge, never frozen. Use a punctured compounded vial within 28 days, or by its label’s date if sooner.
  • At NexLife, compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.
NexLife

One of the most affordable, at every dose. Tirzepatide $139/mo on 12 months, or $169 month to month, all in. Pay less elsewhere? We match it.†About 3 minutes of health questions, no insurance needed. Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you.

Check my eligibility

Units

How many units do you draw from a tirzepatide vial?

Vials are labeled in mg per mL. U-100 syringes are marked in units, and 100 units is 1 mL. So the number of units you draw depends on your vial’s strength, not just your dose: units = your dose in mg ÷ the strength in mg per mL × 100.

Example math only: units of a U-100 syringe at two strengths
DoseAt 10 mg per mLAt 5 mg per mL
2.5 mg0.25 mL = 25 units0.5 mL = 50 units
5 mg0.5 mL = 50 units1 mL = 100 units

Not dosing instructions. Your vial’s strength is on its label, and your prescription tells you your dose. If the numbers don’t match what you were told, stop and call or text us at (949) 818-8000 before you inject.

“Most of the reports indicated that patients were unfamiliar with how to measure the intended dose using a syringe.”

U.S. Food and Drug Administration, FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (July 26, 2024)

Step by step

How do you dose from a tirzepatide vial, step by step?

Four checks before every dose: your label, the units, the numbers, and your prescriber’s schedule.

  1. Check your vial’s label. Find its strength in mg per mL. Your prescription tells you your dose.
  2. Work out the units. Units = your dose in mg ÷ the strength in mg per mL × 100. On a U-100 syringe, 100 units is 1 mL.
  3. Check the numbers before you inject. If they don’t match what you were told, stop and call or text NexLife at (949) 818-8000 first.
  4. Keep to your prescriber’s schedule. Doses step up at least four weeks apart, and your prescriber sets yours. Not everyone needs the highest dose.

The four checks in order: the label, the units, the numbers, then your prescriber’s schedule.

Dosing

How does the tirzepatide dose step up from 2.5 mg to 15 mg?

With FDA-approved tirzepatide, treatment starts at 2.5 mg once a week for four weeks so your body can adjust. From there a clinician can raise the dose in 2.5 mg steps, at least four weeks apart, up to 15 mg. Your prescriber sets your actual schedule, and not everyone needs the highest dose.

  1. 2.5 mg Starter$139/mo
  2. 5 mg$139/mo
  3. 7.5 mg$139/mo
  4. 10 mg$139/mo
  5. 12.5 mg$139/mo
  6. 15 mg Highest dose$139/mo

Weekly dose in mg, and the price per month at each step on the 12-month plan

At NexLife, every step costs the same: $139 a month on a 12-month plan, or $169 month to month, matched if you pay less.† Programs that price by dose charge more as you go up. Ro’s Zepbound, for example, runs from $448 a month at the start to $598 at the highest doses (checked November 1, 2026).

Is drawing tirzepatide from a vial hard?

Drawing your own dose is simpler than it sounds, especially when someone picks up when you ask.

  • Units confuse. The units you draw depend on your vial’s strength.
  • Labels guide. Strength, storage and beyond-use date are printed for your vial.
  • Weekly is easy to forget. A set day and a reminder help.

Clear labels. Real answers. One price.

  • Clear labels. The pharmacy, strength and beyond-use date on every vial.
  • Help when you draw. Call or text us before your first dose; real people answer 24/7.
  • $139 a month on 12 months, at every dose. On a 12-month plan, or $169 month to month. The same price from 2.5 mg to 15 mg.

Real people, real answers. Unsure about units or your label? Ask before you inject. Call or text (949) 818-8000, 24/7.
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.

Choosing

Should you choose a tirzepatide pen or a vial?

Choose a pen if you want the simplest injection and FDA-approved Zepbound, and the price works for you.

Choose a vial if you’re comfortable drawing a dose and want a lower price: compounded tirzepatide is $139 a month on the 12-month plan at NexLife, at every dose. Zepbound vials start at $299 a month at LillyDirect, the same as its KwikPen (checked November 1, 2026).

Either way, it’s a weekly injection under the skin. What changes is the device, the price and, for compounded vials, FDA approval.

“However, compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed.”

U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Red flag

Tirzepatide 30 mg vial: what does “30 mg” mean?

Zepbound’s 4-dose vials hold 10 to 60 mg in all (a 30 mg vial is four 7.5 mg doses), and they come with Lilly’s label and a prescription. Big vials sold any other way online are often “research use only” products. Those aren’t made for people: no prescription, no physician and no pharmacy label. A compounded multiple-dose vial holds several weekly doses, prepared by a state-licensed pharmacy for your prescription.

“Patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy.”

U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

What “research use only” really means.

Vial math

How many units is your tirzepatide dose?

It depends on your vial’s strength. Here are the label’s doses at one example strength, with the math to check your own.

Tirzepatide doses on Zepbound’s label, with the volume and units on a U-100 syringe at an example strength of 25 mg per mL; your vial’s label decides
DosemL at 25 mg/mLUnits (U-100)On the label
2.5 mg0.1 mL10 unitsStarting dose, for 4 weeks
5 mg0.2 mL20 unitsA maintenance dose
7.5 mg0.3 mL30 unitsA step up
10 mg0.4 mL40 unitsA maintenance dose
12.5 mg0.5 mL50 unitsA step up
15 mg0.6 mL60 unitsThe maximum, and a maintenance dose

The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.

25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart.

What would you pay with NexLife?

Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.

Pick one above to see your price.

Check my eligibility
Not today?

Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $139/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $119/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $139/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Tirzepatide pens and vials: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Is a tirzepatide pen better than a vial?

Neither is better medicine; they’re different devices. A pen sets the dose for you, which is simpler; with a vial, you draw each dose with a syringe. At LillyDirect, Zepbound’s KwikPen and vials both start at $299 a month at 2.5 mg (checked November 1, 2026). Compounded tirzepatide, which isn’t FDA-approved, is $139 a month on NexLife’s 12-month plan.

How many units of tirzepatide is 2.5 mg?

It depends on your vial’s strength. At 10 mg per mL, 2.5 mg is 0.25 mL, or 25 units on a U-100 syringe; at 5 mg per mL, it’s 50 units. Always follow the strength on your label and the dose on your prescription. Every dose at every strength: our tirzepatide dosage chart.

What is the Zepbound KwikPen?

It’s a 4-dose, single-patient-use pen that holds a month of weekly Zepbound doses in one device. Through LillyDirect, it starts at $299 a month at 2.5 mg (checked November 1, 2026). Once in use, it can stay in the fridge or at up to 86°F, and its four doses are used within 30 days of first use.

How much do Zepbound vials cost?

At LillyDirect’s self-pay prices, $299 a month at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg to 15 mg with a refill within 45 days ($499 at 7.5 mg and $699 at 10 to 15 mg otherwise), with a prescription (checked November 1, 2026). That’s the medication alone; the prescriber’s fee, if any, is extra.

Can tirzepatide be kept out of the fridge?

Sometimes. A Zepbound single-dose pen or vial can stay at up to 86°F for up to 21 days. An in-use KwikPen or 4-dose vial can stay in the fridge or at up to 86°F, for up to 30 days. For a compounded vial, follow its label; once punctured, the FDA says to discard it within 28 days.

Does compounded tirzepatide come in a pen?

Usually not. Compounded tirzepatide is usually dispensed in multiple-dose vials you draw with a syringe. Prefer no needle at all? NexLife also offers compounded tirzepatide tablets that dissolve under the tongue, $199 a month on a 12-month plan or $229 month to month.

What sizes do tirzepatide vials come in?

Zepbound comes in single-dose vials and 4-dose vials, and the 4-dose vials hold 10 to 60 mg in all, so a 30 mg vial is four 7.5 mg doses. A compounded multiple-dose vial holds several weekly doses, prepared by a state-licensed pharmacy for your prescription.

How much is a tirzepatide 30 mg vial?

LillyDirect doesn’t list Zepbound’s 30 mg vial (four 7.5 mg doses); 7.5 mg there is $449 a month with a refill within 45 days, or $499 without (checked November 1, 2026). Big vials sold any other way online are often “research use only,” not made for people. At NexLife, compounded tirzepatide is $139 a month on the 12-month plan.

Can you buy tirzepatide vials without a prescription?

You shouldn’t. The FDA says to get a prescription from your doctor and fill it at a state-licensed pharmacy. Big vials sold online without one are often “research use only” products, which aren’t made for people: no prescription, no physician and no pharmacy label.

How is a compounded tirzepatide vial different from a Zepbound vial?

Zepbound is FDA-approved; compounded tirzepatide isn’t, so the FDA doesn’t review it for safety, effectiveness or quality before it’s marketed. A compounded multiple-dose vial holds several weekly doses, prepared by a state-licensed pharmacy for your prescription, and you draw each dose with a syringe.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

“No. A generic drug is approved by FDA under 505(j) of the FD&C Act and meets all of the requirements of that section (including establishing therapeutic equivalence to a brand name drug, among others), while a compounded drug is not approved by FDA.”

U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Checked the Zepbound label’s storage rules, LillyDirect’s self-pay prices for the KwikPen and vials, and the FDA’s guidance on compounded vials.

  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.

Paying less elsewhere? We match it.†

A vial, a fair price, a team that answers.

About 3 minutes of health questions. A licensed provider decides if tirzepatide is right for you.

4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
  2. Eli Lilly and Company. Zepbound through LillyDirect.
  3. AJMC. FDA approves monthly KwikPen option for tirzepatide in chronic weight management (February 23, 2026).
  4. U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
  5. NexLife. Compounded tirzepatide plans.
  6. NexLife. Sublingual tirzepatide tablets.
  7. Novo Nordisk. Wegovy (semaglutide) prescribing information.
  8. LegitScript. LegitScript certification record for NexLife.us.
  9. NexLife. Compounded semaglutide plans.
  10. Ro: weight loss program pricing. Checked November 1, 2026.
  11. Hims: Zepbound KwikPen. Checked November 1, 2026.
  12. Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
  13. Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
  14. Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
  15. Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
  16. Eli Lilly and Company, via Drugs@FDA. ZEPBOUND (tirzepatide) injection, for subcutaneous use: prescribing information, revised 02/2026. Read November 2, 2026.
  17. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Read November 2, 2026.
  18. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. Read November 2, 2026.
  19. U.S. Food and Drug Administration. Locate a State-Licensed Online Pharmacy. Read November 2, 2026.
  20. U.S. Food and Drug Administration. Human Drug Compounding Laws. Read November 2, 2026.
  21. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Read November 2, 2026.